中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
1期
78-81
,共4页
己内酯%碳酸亚乙酯%紫杉醇%纳米涂层%血管支架
己內酯%碳痠亞乙酯%紫杉醇%納米塗層%血管支架
기내지%탄산아을지%자삼순%납미도층%혈관지가
ε-aprolactone%Ethylene carbonate%Paclitaxel%Nano-coating%Intravascular stent
目的:构建紫杉醇己内酯(CL)/碳酸亚乙酯(EC)载药纳米涂层,考察其体外释放情况并评价其对血管内皮细胞和平滑肌细胞存活率的影响。方法结合异步降解技术和静电纺织技术制备紫杉醇Poly(CL-co-EC)载药纳米涂层;高压液相色谱法测定载药体系紫杉醇包封率和体外释放曲线;MTT实验测定人血管内皮细胞和平滑肌细胞存活率。结果CL/EC=6和CL/EC=9的紫杉醇Poly(CL-co-EC)的药物包封率分别为92.1%和79.2%;载药量分别为26.5%和18.1%;紫杉醇在体外缓慢释放,50d后累计释放量分别达到78%和37%。紫杉醇Poly(CL-co-EC)电纺薄膜显著降低血管内皮细胞和平滑肌细胞的存活率。结论紫杉醇Poly(CL-co-EC)载药纳米涂层具有缓慢释放和释放速率可控的特点,具有作为血管内支架的潜在价值。
目的:構建紫杉醇己內酯(CL)/碳痠亞乙酯(EC)載藥納米塗層,攷察其體外釋放情況併評價其對血管內皮細胞和平滑肌細胞存活率的影響。方法結閤異步降解技術和靜電紡織技術製備紫杉醇Poly(CL-co-EC)載藥納米塗層;高壓液相色譜法測定載藥體繫紫杉醇包封率和體外釋放麯線;MTT實驗測定人血管內皮細胞和平滑肌細胞存活率。結果CL/EC=6和CL/EC=9的紫杉醇Poly(CL-co-EC)的藥物包封率分彆為92.1%和79.2%;載藥量分彆為26.5%和18.1%;紫杉醇在體外緩慢釋放,50d後纍計釋放量分彆達到78%和37%。紫杉醇Poly(CL-co-EC)電紡薄膜顯著降低血管內皮細胞和平滑肌細胞的存活率。結論紫杉醇Poly(CL-co-EC)載藥納米塗層具有緩慢釋放和釋放速率可控的特點,具有作為血管內支架的潛在價值。
목적:구건자삼순기내지(CL)/탄산아을지(EC)재약납미도층,고찰기체외석방정황병평개기대혈관내피세포화평활기세포존활솔적영향。방법결합이보강해기술화정전방직기술제비자삼순Poly(CL-co-EC)재약납미도층;고압액상색보법측정재약체계자삼순포봉솔화체외석방곡선;MTT실험측정인혈관내피세포화평활기세포존활솔。결과CL/EC=6화CL/EC=9적자삼순Poly(CL-co-EC)적약물포봉솔분별위92.1%화79.2%;재약량분별위26.5%화18.1%;자삼순재체외완만석방,50d후루계석방량분별체도78%화37%。자삼순Poly(CL-co-EC)전방박막현저강저혈관내피세포화평활기세포적존활솔。결론자삼순Poly(CL-co-EC)재약납미도층구유완만석방화석방속솔가공적특점,구유작위혈관내지가적잠재개치。
Objective To establish a nano-coating of paclitaxel loaded ε-aprolactone/Ethylene carbonate copolymer and investigate the release of the nano coating and effects on inhibition ratio of vascular endothelial and smooth muscle cells. Methods The technology of asynchronous degradation and electrostatic spinning technique were used to prepare nano-drug carrier. High pressure liquid chromatography (HPLC) was used to determine the embedding ratio and release curve of paclitaxel loaded nano coating. MTT was applied to test cells survival rate. Results The embedding ratios of paclitaxel in nano-coatings of CL/EC=6 and CL/EC=9 were 92.1%and 79.2%, and drug-loading rate were 26.5% and 18.1%, respectively. Paclitaxel in nano-coatings were slow-release and the accumulative release quantities were 78% and 37% in vitro. The nano-coatings significantly reduced the survival rate of vascular endothelial and smooth muscle cells. Conclusion The nano-coatings of paclitaxel loaded ε-aprolactone/ethylene carbonate copolymer established in this study slowly releases paclitaxel and inhibits the growth of vascular endothelial and smooth muscle cells, which supplies a potential value in stent implantation.